毛細管電泳市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測,按組件、模式、應用、終端用戶、公司和地區分類
市場調查報告書
商品編碼
1289642

毛細管電泳市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測,按組件、模式、應用、終端用戶、公司和地區分類

Capillary Electrophoresis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component, By Mode, By Application, By End User, By Company and By Region

出版日期: | 出版商: TechSci Research | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球毛細管電泳市場預計將在2023-2027年預測期內出現令人矚目的成長。主要因素包括各種類型的癌症、遺傳性疾病和傳染病的發病率不斷增加,對創新療法和藥物的需求不斷增加,以及研發投資的增加,這些都推動了市場的成長。毛細管電泳是一種分離方法,通過施加適當的電壓,根據離子的電泳流動性進行分析分離。它之所以被廣泛使用,是因為其結果更快,分離的解析度高。這種電泳技術被廣泛用於生物科學和臨床研究。支持市場成長的其他因素有:研發活動的增加、蛋白質組學和基因組學研究的增加、個性化醫療需求的增加、老齡化人口的增加、醫療保健支出的增加、電泳在藥物發現領域的應用增加、合併和戰略收購的數量增加、對DNA分析的需求增加以及技術進步。

癌症發病率的上升

患有不同類型癌症的人越來越多,如乳腺癌、宮頸癌、肺癌和其他癌症,這促進了市場的成長。根據美國心臟協會的數據,心血管疾病每年促使1730萬人死亡。由於癌症發病率的上升,對早期診斷和有效治療的需求也在上升,這推動了市場的成長。例如,在2018年,根據國際癌症研究機構(IARC)的數據,全世界有1700萬新的癌症病例和950萬癌症死亡病例。

對個性化醫療的需求不斷增加

如今,對精準醫療的需求正在上升,這是促進市場成長的一個關鍵因素。這要歸功於它有可能以最佳反應定製治療,並減少任何不良事件。它基本上是通過使用病人的遺傳學和其他基本分子資訊來進行有效的治療。例如,在2020年,根據進展報告的範圍和意義,專門藥物報告約佔該年美國食品和藥物管理局批准的新藥總數的39%。

研究和開發活動的上升

醫學和生物化學領域的研發活動數量的上升正在推動市場的成長。由於遺傳性疾病、傳染病和癌症的增加,治療的複雜性增加,正在推動全球市場的成長。在各個領域,如基因組學和蛋白質組學,擴大採用測序技術,以及測序成本的降低都在支持市場的成長。此外,政府和非政府組織對研究和開發活動的大量投資以及對特定疾病的基因組研究的撥款正在推動市場的成長。例如,製藥公司輝瑞公司將其研發支出從2019年的86.5億美元提高到2020年的94億美元。

可用的定製服務

利用給定的市場數據,TechSci Research根據公司的具體需求提供定製服務。該報告可提供以下定製選項:

公司資訊

  • 其他市場參與者(最多5家)的詳細分析和簡介。

目錄

第一章:產品概述

第二章:研究方法

第三章:執行摘要

第四章:COVID-19對全球毛細管電泳市場的影響

第五章:客戶的聲音

第六章:全球毛細管電泳的市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按組件(儀器、耗材、軟體)分類
    • 按模式(毛細管區間電泳、毛細管電色譜、其他)分類
    • 按應用(核酸分析v/ 蛋白質分析)分類
    • 按終端用戶(生物技術和製藥公司、臨床實驗室、學術和研究機構、其他)分類
    • 按公司分類(2021年)
    • 按地區分類
  • 市場地圖

第七章:北美毛細管電泳的市場前景

  • 市場規模和預測
    • 按價值分類
  • 市場佔有率與預測
    • 按組件(儀器、耗材、軟體)分類
    • 按模式(毛細管區間電泳、毛細管電色譜、其他)分類
    • 按應用(核酸分析v/ 蛋白質分析)分類
    • 按終端用戶(生物技術和製藥公司、臨床實驗室、學術和研究機構、其他)分類
    • 按國家分類
  • 北美洲:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第八章:歐洲毛細管電泳的市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按組件(儀器、耗材、軟體)分類
    • 按模式(毛細管區間電泳、毛細管電色譜、其他)分類
    • 按應用(核酸分析v/ 蛋白質分析)分類
    • 按終端用戶(生物技術和製藥公司、臨床實驗室、學術和研究機構、其他)分類
    • 按國家分類
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第九章:亞太地區毛細管電泳的市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按組件(儀器、耗材、軟體)分類
    • 按模式(毛細管區間電泳、毛細管電色譜、其他)分類
    • 按應用(核酸分析v/ 蛋白質分析)分類
    • 按終端用戶(生物技術和製藥公司、臨床實驗室、學術和研究機構、其他)分類
    • 按國家分類
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第十章:南美毛細管電泳的市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按組件(儀器、耗材、軟體)分類
    • 按模式(毛細管區間電泳、毛細管電色譜、其他)分類
    • 按應用(核酸分析v/ 蛋白質分析)分類
    • 按終端用戶(生物技術和製藥公司、臨床實驗室、學術和研究機構、其他)分類
    • 按國家分類
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章:中東和非洲毛細管電泳的市場前景

  • 市場規模和預測
    • 按價值計算
  • 市場佔有率與預測
    • 按組件(儀器、耗材、軟體)分類
    • 按模式(毛細管區間電泳、毛細管電色譜、其他)分類
    • 按應用(核酸分析v/ 蛋白質分析)分類
    • 按終端用戶(生物技術和製藥公司、臨床實驗室、學術和研究機構、其他)分類
    • 按國家分類
  • MEA: 國家分析
    • 南非毛細管電泳
    • 沙烏地阿拉伯毛細管電泳
    • 阿拉伯聯合大公國毛細管電泳
    • 土耳其毛細管電泳
    • 埃及毛細管電泳

第十二章:市場動態

  • 驅動力
  • 挑戰

第十三章:市場趨勢與發展

第十四章:競爭格局

  • QIAGEN NV
  • Thermo Fischer Scientific, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Merck KGaA
  • Promega Corporation
  • Shimadzu Corporation
  • LABGENE Scientific SA

第十五章:戰略建議

簡介目錄
Product Code: 12992

The global capillary electrophoresis market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include growing incidences of various types of cancers, genetic disorders, and infectious diseases, growing demand for innovative therapies and drugs, and an increase in investments in R&D are propelling the growth of the market. Capillary electrophoresis is a separation method that separates ions analytically based on their electrophoretic mobility by applying a suitable voltage. It is used predominately because of the faster results and separates with high resolution. This electrophoresis technique is extensively used in biosciences and clinical research. The other factors supporting the market's growth are, rise in R&D activities, increased proteomics, and genomics research, increasing demand for personalized medicine, growing aging population base, increasing healthcare expenditure, increasing application of electrophoresis in the field of drug discovery, growing number of mergers and strategic acquisitions, increasing need for DNA analysis, and technological advancements.

Rising Prevalence of Cancer

The growing number of people suffering from different types of cancer, such as breast cancer, cervical, lung, and others, is augmenting the growth of the market. As per the American Heart Association, cardiovascular diseases cause 17.3 million deaths per year. Owing to the rise in incidences of cancer, the demand for early diagnosis and effective treatment is also rising, which fuels the growth of the market. For instance, in 2018, as per the International Agency for Research on Cancer (IARC), there were 17.0 million new cancer cases and 9.5 million cancer deaths across the world.

Increasing Demand for Personalized Medicine

Nowadays, the demand for precision medicine is rising, which is a key factor in bolstering the growth of the market. This is attributed to its potential to tailor therapy with the best response and to reduce any adverse events. It is basically used to have effective treatment by using a patient's genetics and other essential molecular information. For instance, in 2020, according to the scope and significance of the progress report, specialized medicines reported for about 39 percent of the total FDA-approved new drugs in the year.

Rise in Research and Development Activities

The rise in the number of R&D activities in the medical and biochemistry sector is fueling the growth of the market. Owing to the rise in genetic disorders, infectious diseases, and cancer, an increase in complexities in treatments is surging the growth of the market globally. Increasing adoption of sequencing in various fields, such as genomics and proteomics, and reduction in the cost of sequencing are supporting the growth. Furthermore, heavy investments by government and non-government organizations for research and development activities and grants for specific disease-targeted genomic research are fueling the growth of the market. For instance, pharmaceutical company Pfizer enhanced their R&D expenditure from $8.65 billion in 2019 to $9.4 billion in 2020.

Market Segmentation

The global capillary electrophoresis market is segmented into component, mode application, end user, and company. Based on components, the market is divided into instruments, consumables, and software. Based on mode, the market is divided into capillary zone electrophoresis, capillary electrochromatography, and others. Based on application, the market is divided into nucleic acid analysis and protein analysis. Based on nucleic acid analysis, the market is further segmented into DNA fragment analysis and RNA/mRNA analysis. Based on end-user, the market is divided into biotechnology & pharmaceutical companies, clinical laboratories, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising research and development (R&D) activities in the country.

Market Players

QIAGEN NV, Thermo Fischer Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, PerkinElmer, Inc., Merck KGaA, Promega Corporation, Shimadzu Corporation, and LABGENE Scientific SA are some of the leading companies operating in the market.

Report Scope

In this report, global capillary electrophoresis market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Capillary Electrophoresis Market, By Component:

  • Instruments
  • Consumables
  • Software

Capillary Electrophoresis Market, By Mode:

  • Capillary Zone Electrophoresis
  • Capillary Electro Chromatography
  • Others

Capillary Electrophoresis Market, By Application:

  • Nucleic Acid Analysis
    • DNA Fragment Analysis
    • RNA/mRNA Analysis
  • Protein Analysis

Capillary Electrophoresis Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Clinical Laboratories
  • Academic & Research Institutions
  • Others

Capillary Electrophoresis Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Capillary Electrophoresis Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Capillary Electrophoresis Market

5. Voice of Customer

6. Global Capillary Electrophoresis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component (Instruments, Consumables, Software)
    • 6.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 6.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 6.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 6.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region
  • 6.3. Market Map

7. North America Capillary Electrophoresis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component (Instruments, Consumables, Software)
    • 7.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 7.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 7.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 7.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Capillary Electrophoresis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Mode
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Capillary Electrophoresis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Mode
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Capillary Electrophoresis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Mode
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Capillary Electrophoresis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component (Instruments, Consumables, Software)
    • 8.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 8.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 8.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 8.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Capillary Electrophoresis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Mode
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Capillary Electrophoresis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Mode
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Capillary Electrophoresis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Mode
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Capillary Electrophoresis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Mode
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Capillary Electrophoresis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Mode
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Capillary Electrophoresis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component (Instruments, Consumables, Software)
    • 9.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 9.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 9.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 9.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Capillary Electrophoresis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Mode
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Capillary Electrophoresis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Mode
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Capillary Electrophoresis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Mode
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Capillary Electrophoresis Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Component
        • 9.3.4.2.2. By Mode
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Capillary Electrophoresis Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Component
        • 9.3.5.2.2. By Mode
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Capillary Electrophoresis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component (Instruments, Consumables, Software)
    • 10.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 10.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 10.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 10.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Capillary Electrophoresis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Mode
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Capillary Electrophoresis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Mode
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Capillary Electrophoresis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Mode
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Capillary Electrophoresis Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Component (Instruments, Consumables, Software)
    • 11.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 11.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 11.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 11.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Capillary Electrophoresis Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Component
        • 11.3.1.2.2. By Mode
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Capillary Electrophoresis Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Component
        • 11.3.2.2.2. By Mode
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Capillary Electrophoresis Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Component
        • 11.3.3.2.2. By Mode
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User
    • 11.3.4. Turkey Capillary Electrophoresis Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Component
        • 11.3.4.2.2. By Mode
        • 11.3.4.2.3. By Application
        • 11.3.4.2.4. By End User
    • 11.3.5. Egypt Capillary Electrophoresis Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Component
        • 11.3.5.2.2. By Mode
        • 11.3.5.2.3. By Application
        • 11.3.5.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. QIAGEN NV
  • 14.2. Thermo Fischer Scientific, Inc.
  • 14.3. Agilent Technologies, Inc.
  • 14.4. Bio-Rad Laboratories, Inc.
  • 14.5. Danaher Corporation
  • 14.6. PerkinElmer, Inc.
  • 14.7. Merck KGaA
  • 14.8. Promega Corporation
  • 14.9. Shimadzu Corporation
  • 14.10. LABGENE Scientific SA

15. Strategic Recommendations